Open access · US-GOV via ClinicalTrials.gov Clinical trial

Effects of Obesity on Rectus Femoris Muscle Thickness, Sarcopenia, Gait and Balance in Women

Authors not listed

Kutahya Health Sciences University · 2022

Mitochondrial dysfunction Human Randomized controlled trial

Abstract

Research; It is a planned, non-invasive, controlled study in obese female volunteers and non-obese female volunteers. The population of the study consists of voluntarily non-obese women and obese women. Sarcopenia assets of individuals will be measured with the sarc-f questionnaire, and then muscle strength, muscle mass and physical performance tests will be measured. Then, rectus femoris muscle thickness will be measured with USG, and then walking and balance will be measured with ZEBRIS.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-07-02 MST

Cite this

APA

Anonymous. (2022). Effects of Obesity on Rectus Femoris Muscle Thickness, Sarcopenia, Gait and Balance in Women. <em>Kutahya Health Sciences University</em>. https://clinicaltrials.gov/study/NCT05638035

Vancouver

Anonymous. Effects of Obesity on Rectus Femoris Muscle Thickness, Sarcopenia, Gait and Balance in Women. Kutahya Health Sciences University. 2022.

BibTeX

@misc{anon2022Effect, title = {Effects of Obesity on Rectus Femoris Muscle Thickness, Sarcopenia, Gait and Balance in Women}, author = {Anonymous}, journal = {Kutahya Health Sciences University}, year = {2022}, }